Annovis Bio, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €180.06M +519.6% -€23.53M -68.3% -13.1% +2.4 pp -€10.18M -92.4% -5.7% +4.6 pp
    (estimated) €29.06M +∞% -€74.20M +53.0% -255.3% -2.6 pp -€133.96M +129.7% -461.0% -4.6 pp
    (estimated) €0.00 +NaN% -€48.50M +21.9% N/A -€58.31M +22.9% N/A
    (estimated) €0.00 +NaN% -€39.77M +59.9% N/A -€47.44M +95.0% N/A
    (estimated) €0.00 +NaN% -€24.87M -99.9% N/A -€24.33M -99.9% N/A
    €0.00 +NaN% -€21.21B +43,652.0% N/A -€18.89B +54,681.3% N/A
    €0.00 +NaN% -€48.48M +121.9% N/A -€34.48M +130.9% N/A
    €0.00 +NaN% -€21.85M +74.8% N/A -€14.93M +89.6% N/A
    €0.00 +NaN% -€12.50M +165.2% N/A -€7.88M +130.0% N/A
    €0.00 +NaN% -€4.71M +451.2% N/A -€3.43M +733.3% N/A
    €0.00 +NaN% -€854.83K +38.8% N/A -€411.06K -14.7% N/A
    €0.00 +NaN% -€615.89K +4.7% N/A -€481.85K +3.9% N/A
    €0.00 -€588.29K N/A -€463.63K N/A

    Notifications